High Court Shakes Head At Hytrin Settlement Case
By Erin Marie Daly ( January 10, 2007, 12:00 AM EST) -- The U.S. Supreme Court has declined to take on the case of seven major health care providers who were seeking the right to opt out of a $15 million antitrust class action settlement over patent rights to the drug Hytrin after they missed a filing deadline due to a mail delay....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.